SCHEMBL5237309

SCHEMBL5237309

CC(=O)NCCCOC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
MAPK1 P28482 1/20 0.58
HIF1A Q16665 1/20 0.58
ALDH1A1 P00352 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
PAOX Q6QHF9 3/20 0.48
ADRA1A P35348 1/20 0.47
MTNR1A P48039 2/20 0.44
MTNR1B P49286 2/20 0.44
FAAH O00519 1/20 0.44
ACHE P22303 7/20 0.44
TSHR P16473 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA3 P07451 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11441088 0.93 KDM4E (0.62) KDM4EMAPK1HIF1AALDH1A1L3MBTL1
SCHEMBL7445070 0.91 KDM4E (0.67) KDM4EMAPK1HIF1AALDH1A1L3MBTL1
SCHEMBL9491670 0.91 KDM4E (0.67) KDM4EMAPK1HIF1AALDH1A1L3MBTL1
SCHEMBL29315300 0.91 KDM4E (0.67) KDM4EMAPK1HIF1AALDH1A1L3MBTL1
SCHEMBL16312310 0.86 ALDH1A1 (0.54) KDM4EMAPK1HIF1AALDH1A1FAAH
SCHEMBL279485 0.86 MAPK1 (0.50) KDM4EMAPK1HIF1AALDH1A1PAOX
SCHEMBL17578778 0.84 ALDH1A1 (0.52) KDM4EMAPK1HIF1AALDH1A1FAAH
SCHEMBL17578616 0.83 TSHR (0.57) KDM4EALDH1A1FAAHACHETSHR
SCHEMBL67905 0.81 ALDH1A1 (0.58) ALDH1A1PAOXFAAHACHETSHR
SCHEMBL18412265 0.81 ATM (0.55) KDM4EMAPK1HIF1AL3MBTL1PAOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239934-A1 FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE TOSOH CORPORATION (JP) 2024-07-18 US disclosed
EP-1380121-B1 PROCESS TO PREPARE OXAZOLIDINONES PHARMACIA & UPJOHN CO LLC (US) 2007-09-26 EP disclosed
US-7087784-B2 Process to prepare oxazolidinones PHARMACIA & UPJOHN (US) 2006-08-08 US disclosed
US-6887995-B2 Process to prepare oxazolidinones PHARMACIA & UPJOHN COMPANY (US) 2005-05-03 US disclosed
US-20040220407-A1 Process to prepare oxazolidinones PERRAULT WILLIAM R 2004-11-04 US disclosed
EP-1380121-A2 PROCESS TO PREPARE OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY (US) 2004-01-14 EP disclosed
US-20020169312-A1 Process to prepare oxazolidinones PHARMACIA & UPJOHN COMPANY 2002-11-14 US disclosed
WO-2002085849-A2 PROCESS TO PREPARE OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY (US) 2002-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040220407-A1 Process to prepare oxazolidinones CYP3A5, OXA1L, CYP3A4 KDM4E 1853/4885MAPK1 1862/4885HIF1A 1792/4885
US-20020169312-A1 Process to prepare oxazolidinones CYP3A5, OXA1L, CYP3A4 KDM4E 1853/4885MAPK1 1862/4885HIF1A 1792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.